Cannabinoids in treating Parkinson's disease symptoms: a systematic review of clinical studies

K Varshney, A Patel, S Ansari, P Shet… - Cannabis and …, 2023 - liebertpub.com
Background: Parkinson's disease (PD) is a serious neurodegenerative condition impacting
many individuals worldwide. There is a need for new non-invasive treatments of PD …

Advice to People with Parkinson's in My Clinic: Cannabis

MET de Freitas, SH Fox - Journal of Parkinson's Disease, 2024 - content.iospress.com
Cannabis (in all the varied methods of delivery) continues to garner significant attention as a
potential therapeutic intervention for neurodegenerative disorders, including Parkinson's …

Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson's disease

J Reiner, L Franken, E Raveh, I Rosset… - Journal of Neural …, 2023 - Springer
Abnormalities of oculometric measures (OM) are widely described in people with
Parkinson's disease (PD). However, knowledge of correlations between abnormal OM …

Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´ s Disease

M Peball, B Heim, F Carbone, O Schorr… - npj Parkinson's …, 2024 - nature.com
The synthetic tetrahydrocannabinol-analog nabilone improved non-motor symptoms (NMS)
in Parkinson's disease (PD) patients in a placebo-controlled, double-blind, parallel-group …

Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial

E Raveh, A Ben-Shimon, V Anisimov… - … Lateral Sclerosis and …, 2023 - Taylor & Francis
Objective: Oculometric measures (OM) can be extracted from eye movements during
presentation of visual stimuli. Studies have indicated the benefit of OM in assessment of …

Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progression

O Berkman, E Raveh, E Harpaz… - … Lateral Sclerosis and …, 2024 - Taylor & Francis
Abstract Objective: Saccadic Intrusions (SIs) are abnormal eye movements during gaze
fixation. Studies have indicated the clinical relevance of SIs, especially of square wave jerks …

Fiber Activation by Bipolar Stimulation in Deep Brain Stimulation: A Patient Case Study

AF Frigge, E Jiltsova, F Olsson, D Nyholm… - arXiv preprint arXiv …, 2024 - arxiv.org
Deep Brain Stimulation (DBS) is a therapy widely used for treating the symptoms of
neurological disorders. Electrical pulses are chronically delivered in DBS to a disease …

Efetividade e segurança do uso da Cannabis sativa no tratamento dos sintomas não-motores na Doença de Parkinson: Uma revisão de escopo

GC Piloto, JC da Silva, KC Germann… - Research, Society and …, 2024 - rsdjournal.org
Objective: To map and analyze the evidence available in the existing literature on the
effectiveness and safety of the use of Cannabis sativa in the treatment of Non-Motor …

[HTML][HTML] Short-Term Therapy With a High Cannabidiol/Low Δ-9-Tetrahydrocannabinol Formulation in Patients With Parkinson's Disease

SA Isfahani, ME de Freitas - practiceupdate.com
This randomized, double-blind, placebo-controlled trial involving 61 participants examined
the short-term efficacy and tolerability of a high cannabidiol (CBD) and low Δ-9 …

[HTML][HTML] Inhalers, Cannabis Use Disorder, and Parkinson's Disease: Weekly Cannabis News May 20th-May 27th 2022

L Smith - csequence.com
Medical cannabis has long been viewed as an alternative agent to treat pain for a wide array
of medical conditions and as such is on the rise worldwide.[1] However, the combination of …